Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)

Name: Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, trifarotine and upadacitinib to the Prescription Drug List (PDL) for human and/or veterinary use.